Comprehensive analysis of advanced-stage solid tumors from TCGA reveal widespread variation of genomics evidence levels across cancer types.

Dilhan Weeraratne(IBM (United States)), Jane Snowdon(IBM (United States)), Rodrigo Fernandes Ramalho(Fleury S.A. (Brazil)), Matheus Carvalho Bürger(Fleury S.A. (Brazil)), Miguel Mitne‐Neto(Hospital Santa Paula), Hu Huang(Carnegie Mellon University), David Brotman(IBM (United States)), Aloisio Souza Felipe-Silva(Fleury S.A. (Brazil)), Elisa Napolitano Ferreira(AC Camargo Hospital)
Journal of Clinical Oncology
May 20, 2020
Cited by 0


Related Papers